GHRP-2 Acetate 5mg × 10 vials

A synthetic growth hormone secretagogue studied for GH-release research, ghrelin receptor pathways, IGF-1 signaling, endocrine regulation, appetite-related mechanisms, muscle-tissue models, and broader recovery-related research protocols.

Product Overview

Compound: GHRP-2 Acetate
Strength: 5 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 5 mg
BAC water: 2 mL
Amount per unit: 25 mcg per unit

Research Dose

Protocol dependent.

Notes

GHRP-2 Acetate is described as a synthetic growth hormone-releasing peptide and growth hormone secretagogue receptor agonist. It has been studied for its ability to stimulate growth hormone release through ghrelin receptor-related pathways.

Research literature has examined GHRP-2 in relation to GH pulsatility, IGF-1 signaling, appetite-regulation mechanisms, endocrine function, muscle-tissue research, recovery-related pathways, and body-composition models.

GHRP-2 is primarily associated with growth hormone secretagogue and endocrine research. It should not be treated as a standard wellness, performance, or consumer-use peptide.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.